VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CON
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CONConcentra Group Holdings Parent, Inc.
$36.40$4.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCONFinancials

Concentra Group Holdings Parent, Inc. (CON) Income Statement

4Y historyFree accessUpdated daily

Revenue growth accelerated to 10.0% YoY in Q2 2026 with gross margin expanding to 31.7% from 25.3% in Q2 2024, driving EPS up 47.1% to $0.50.

Income StatementBalance SheetCash FlowRatios

CON Income Statement

Annual statement

CON Income Statement

Concentra Group Holdings Parent, Inc. (CON) annual income statement — 4-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22
Sales/Revenue2.29B2.16B1.9B1.84B1.72B
Revenue Growth %14.02%13.85%3.38%6.59%-
Cost of Goods Sold1.62B1.55B1.37B1.33B1.32B
COGS % of Revenue-71.66%72.21%72.12%76.33%
Gross Profit670.56M613.09M527.98M512.43M408.19M
Gross Margin %29.31%28.34%27.79%27.88%23.67%
Gross Profit Growth %-16.12%3.03%25.54%-
Operating Expenses295.75M-1.47B223.21M224.8M149.98M
OpEx % of Revenue--68.16%11.75%12.23%8.7%
Selling, General & Admin213.41M203.31M156.32M152M149.98M
SG&A % of Revenue-9.4%8.23%8.27%8.7%
Research & Development00000
R&D % of Revenue-----
Other Operating Expenses4M-1.68B66.89M72.8M0
Operating Income374.81M2.09B304.76M287.63M258.22M
Operating Margin %16.39%96.5%16.04%15.65%14.97%
Operating Income Growth %-584.99%5.96%11.39%-
EBITDA454.56M2.16B371.94M360.68M331.88M
EBITDA Margin %19.87%100%19.57%19.62%19.25%
EBITDA Growth %19.11%481.65%3.12%8.68%-
D&A (Non-Cash Add-back)79.75M75.82M67.18M73.05M73.67M
EBIT380.02M333.07M301.09M287.1M256.54M
Net Interest Income-107.28M-109.29M-69.69M-114.04M-31.64M
Interest Income00000
Interest Expense107.28M109.29M69.69M114.04M31.64M
Other Income/Expense-107.28M-1.86B-73.37M-45M-33.32M
Pretax Income267.53M223.78M231.39M242.63M224.9M
Pretax Margin %11.7%10.34%12.18%13.2%13.04%
Income Tax61.93M50.98M59.5M57.89M52.65M
Effective Tax Rate %23.15%22.78%25.71%23.86%23.41%
Net Income198.73M172.8M166.54M179.95M166.73M
Net Margin %8.69%7.99%8.76%9.79%9.67%
Net Income Growth %33.09%3.76%-7.45%7.93%-
Net Income (Continuing)205.6M172.8M171.9M184.74M172.24M
Discontinued Operations00000
Minority Interest29.33M27.15M23.05M21.84M22.8M
EPS (Diluted)1.551.301.301.421.32
EPS Growth %31.62%0%-8.45%7.58%-
EPS (Basic)-1.391.301.421.32
Diluted Shares Outstanding128.17M128.17M128.13M126.59M126.59M
Basic Shares Outstanding126.65M126.65M128.13M126.59M126.59M
Dividend Payout Ratio-18.56%926.87%3.41%-

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetStrained
Cash FlowRobust
Top Statement Risk

Elevated leverage and CEO transition

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Accelerating Revenue Momentum

Revenue grew 10.0% year-over-year in Q2 2026 to $606.0M, accelerating from 5.5% in Q4 2024, according to the latest quarterly report.

The sequential acceleration from 5.5% in Q4 2024 to 10.0% in Q2 2026 suggests strengthening demand in occupational health services, likely tied to robust employment in blue-collar sectors. The consistent quarterly revenue increases, from $465.0M in Q4 2024 to $606.0M in Q2 2026, indicate a durable growth trajectory. Investors should monitor whether this pace is sustainable given potential cyclicality in industrial employment.

Gross Margin Expansion Amid Cost Pressures

Gross margin improved to 31.7% in Q2 2026 from 25.3% in Q2 2024, as reported in financial statements, despite ongoing clinical labor cost inflation.

The 640 basis point expansion in gross margin over eight quarters suggests effective cost management or favorable payer mix, though the 28.34% average gross margin remains below peers like AMSF. The improvement may reflect operational efficiencies and scale benefits, but the sustainability is uncertain given fixed reimbursement rates and potential wage inflation. The recent earnings beat indicates that current cost pressures are manageable, but investors should watch for margin compression if labor costs escalate.

Operating Leverage Driving Profitability

Operating income grew 28.6% year-over-year in Q2 2026 to $115.1M, outpacing revenue growth of 10.0%, as per the income statement data.

The operating margin expanded from 16.3% in Q2 2025 to 19.0% in Q2 2026, indicating that SG&A costs are scaling slower than revenue. SG&A as a percentage of revenue declined from 9.6% to 9.4% over the same period, suggesting disciplined overhead control. This operating leverage appears to be a key driver of the earnings beat, but it may be partly due to one-time items, given the anomalous 96.5% operating margin in the broader data.

Earnings Quality Supported by Low SBC

Net income rose to $65.3M in Q2 2026 with EPS of $0.50, while stock-based compensation was only $4.1M, based on the latest quarterly figures.

The low SBC relative to net income (6.3%) suggests that reported earnings are not significantly diluted by non-cash compensation, enhancing earnings quality. However, the net margin of 10.8% is below the peer average, and the tax rate appears stable. The absence of R&D expenses is typical for a service provider, but investors should note the potential for one-time gains or adjustments in the carve-out financials.

COGS Dominates Cost Structure

COGS accounted for 68.3% of revenue in Q2 2026, totaling $413.9M, as reported in the income statement, reflecting high clinical labor costs.

The cost structure is heavily weighted toward COGS, which includes clinical salaries and facility costs, leaving limited room for cost reduction without impacting service quality. SG&A is relatively lean at 9.4% of revenue, indicating efficient overhead management. The recent gross margin improvement suggests that management has been able to control COGS growth, but the reliance on labor makes the model sensitive to wage inflation.

Q2 2026 Marks Operational Inflection

Q2 2026 showed a significant inflection with EPS of $0.50 versus $0.34 in Q2 2025, a 47.1% increase, according to the quarterly earnings data.

This quarter represents a clear inflection point, with revenue, operating income, and net income all reaching multi-quarter highs. The 47.1% EPS growth, driven by both revenue acceleration and margin expansion, suggests that the company is benefiting from operational leverage and possibly favorable one-time items. The raised guidance following this beat indicates management's confidence in sustained momentum, but the CEO transition introduces uncertainty about future execution.

Leverage and Leadership Risks

Despite strong Q2 2026 results, debt-to-equity stands at 5.0x, and the CEO departure introduces leadership uncertainty, as noted in recent disclosures.

The elevated leverage, while manageable given robust cash flow, could amplify financial risk if operational performance falters. The CEO transition after a decade of leadership may lead to strategic shifts or loss of operational discipline, which could impact the recent margin improvements. Additionally, the anomalous 96.5% operating margin in the data suggests potential reporting artifacts that may overstate underlying profitability, warranting caution in extrapolating current trends.

CON — Frequently Asked Questions

Quick answers to the most common questions about buying CON stock.

What was Concentra Group Holdings Parent, Inc.'s (CON) revenue in 2025?

For fiscal year 2025, Concentra Group Holdings Parent, Inc. (CON) reported total revenue of $2.16B. This represents a 25.5% increase compared to $1.72B in 2022.

Is Concentra Group Holdings Parent, Inc. (CON) profitable?

Concentra Group Holdings Parent, Inc. (CON) is profitable, generating $172.8M in net income for the fiscal year ending 2025 with a net profit margin of 8.0%.

What is Concentra Group Holdings Parent, Inc.'s operating profit margin?

Concentra Group Holdings Parent, Inc. (CON) reported an operating income of $2.09B, resulting in an operating profit margin of 96.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Concentra Group Holdings Parent, Inc.'s gross profit and gross margin?

Concentra Group Holdings Parent, Inc. (CON) generated $613.1M in gross profit for the year, representing a gross profit margin of 28.3%. This demonstrates the company's core pricing power and production efficiency.